Skip to main content
OpenTrials

Clinical trial condition

Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted

Explore clinical trials studying Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted trial results

Recruiting

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

NCT05303519

Conditions
Astrocytoma, Astrocytoma, Grade IV, Astrocytoma, IDH-Mutant, Grade 2, +22 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • University of California San Diego La Jolla, California, United States
View all 57 locations
View Trial Details

Related conditions